Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

mint Lesion screenshot with PET evaluation, SUV, customized response criteria

Customizable reading templates for therapy response assessment

mint Lesion offers customizable reading templates for therapy response assessment in clinical care and research. Adapt parameters, define lesion categories, and evaluate responses. Track key measurements like diameter, volume, SUV, and ADC, ensuring compliance with required minimum sizes. Automate sum calculations for response determination and integrate clinical data such as ctDNA or PSA values. Document multiple lesions, compare absolute and relative changes over time, and visualize trends with interactive charts. Generate comprehensive reports with tables and graphs for a clear longitudinal overview.

Key features:

  • Easily customizable parameters
    • Questions for manual response evaluation
    • Lesion categories (e.g., target lesions, non-target lesions)
    • System-derived lesion states (e.g., normalized for lymph nodes)
    • Key measurement values (e.g., longest diameter, short axis, volume, SUV, ADC, etc.), including required minimum size for each lesion category
    • Sum of measurements for response determination (e.g., sum of diameter or sum of volume)
    • Clinical data (e.g., ctDNA or PSA values)
  • Ability to document the count of multiple (non-target and new) lesions
  • Automatic calculations of absolute and relative differences to baseline, previous timepoint and nadir
  • Interactive charts displaying all relevant values over time, including clinical data, with dynamic filtering options
  • Comprehensive reports including tables and graphs for a fast and clear longitudinal overview

Related Resources

Related Resources

Objective, reproducible, and trustworthy data in clinical trials with imaging endpoints

Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials…

University Hospital Jena: Study evaluated response rate and safety in patients with HCC treated with DEB-TACE using 40-µm microspheres

Researchers at the University Hospital Jena analyzed the response rate and safety of superselective drug-eluting beads transarterial chemoembolization…

University Hospital Tübingen: Study examined correlation between 18f-fdg PET and CT texture parameters in metastatic melanoma patients

An exploratory study [1] conducted by researchers at University Hospital Tuebingen investigated whether CT texture analysis parameters correlate with…